Use of Drug Coated Balloons in Bifurcation Lesions

Dr. Ezgi Polat Ocaklı

Ankara Etlik City Hospital, Department of Cardiology, Ankara, Türkiye

ABSTRACT

Percutaneous coronary interventions (PCIs) for coronary bifurcation lesions are often complex and associat- ed with unsatisfactory results. Provisional side branch (SB) stenting technique is recommended for coronary bifurcation lesions (CBLs), but some complications related to main branch (MB) stenting may occur. In com- plex CBLs, MB and SB stenting techniques (dual stenting technique) are used respectively, and it is seen that this technique does not always give better results than provisional stenting in the long term. Considering the weaknesses of these techniques, drug coated balloons (DCB) are emerging as a new and alternative therapy in the treatment of coronary bifurcations as they simplify the procedure and reduce the rates of stent-related complications.

Keywords: Percutaneous coronary intervention; Coronary artery disease; Drug-eluting balloon; In-stent restenosis

Referanslar

  1. Sawaya FJ, Lefevre T, Chevalier B, Garot P, Hovasse T, Morice MC, Rab T, Louvard Y. Contemporary approach to coronary bifurcation lesion treatment. JACC Cardio- vasc Interv. 2016;9(18):1861-78. [Crossref]  [PubMed]
  2. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascular- ization. Eur Heart J. 2019 Jan 7;40(2):87-165. [Crossref]  [PubMed]
  3. Brar SS, Gray WA, Dangas G, Leon MB, Aharonian VJ, Brar SK et al. Bifurcation stenting with drug-eluting stents: a sys- tematic review and meta-analysis of randomised trials. Euro- Intervention. 2009 Sep;5(4):475-84. [Crossref]  [PubMed]
  4. Koo BK, Kang HJ, Youn TJ, Chae IH, Choi DJ, Kim HS et al. Physiologic assessment of jailed side branch lesions using fractional flow reserve. J Am Coll Cardiol. 2005 Aug 16;46(4):633-7. [Crossref]  [PubMed]
  5. Burzotta F, Lassen JF, Lefevre T, Banning AP, Chatzizisis YS, Johnson TW, et al. Percutaneous coronary interven- tion for bifurcation coronary lesions: the 15th consensus document from the European bifurcation club. Euro inter- vention. 2021;16(16):1307-17. [Crossref]  [PubMed]  [PMC]
  6. Gwon H, Song YB, Pan M. The story of plaque shift and carina shift. EuroIntervention. 2015; 11 Suppl V: V75-V77. [Crossref]  [PubMed]
  7. Xu J, Hahn J, Song YB, Choi S, Choi J, Lu C, et al. Cari- na shift versus plaque shift for aggravation of side branch ostial stenosis in bifurcation lesions: volumetric intravascu- lar ultrasound analysis of both branches. Circulation. Car- diovascular Interventions. 2012; 5: 657-662. [Crossref]  [PubMed]
  8. Karanasos A, Tu S, van der Heide E, Reiber JH, Regar E. Carina shift as a mechanism for side-branch compromise following main vessel intervention: insights from three-di- mensional optical coherence tomography. Cardiovascu- lar Diagnosis and Therapy. 2012; 2: 173-177. [Link]
  9. Nakamura T, Okamura T, Fujimura T, Yamada J, Nao T, Tateishi H, et al. Serial changes in the three-dimensional as- pect of the side-branch ostium jailed by a drug-eluting stent assessed by optical coherence tomography. The Internation- al Journal of Cardiovascular Imaging. 2017; 33: 797-806. [Crossref]  [PubMed]
  10. Fujimura T, Okamura T, Tateishi H, Nakamura T, Yamada J, Oda T, et al. Serial changes in the side-branch ostial area after main-vessel stenting with kissing balloon inflation for coronary bifurcation lesions, assessed by 3D optical coher- ence tomography. European Heart Journal. Cardiovascular Imaging. 2018; 19: 1117-1125. [Crossref]  [PubMed]
  11. Hildick-Smith D, Lassen JF, Albiero R, Lefevre T, Darre- mont O, Pan M, et al. European Bifurcation Club. Consensus from the 5th European Bifurcation Club meeting. EuroInt- ervention. 2010 May;6(1):34-8. [Crossref]  [PubMed]
  12. Hildick-Smith D, Behan MW, Lassen JF, Chieffo A, Lefèvre T, Stankovic G, et al. The EBC TWO Study (European Bi- furcation Coronary TWO): A Randomized Comparison of Provisional T-Stenting Versus a Systematic 2 Stent Culotte Strategy in Large Caliber True Bifurcations. Circ Cardiovasc Interv. 2016 Sep;9(9):e003643. [Crossref]  [PubMed]
  13. Behan MW, Holm NR, de Belder AJ, Cockburn J, Erglis A, Curzen NP, et al. Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-lev- el pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study. Eur Heart J. 2016 Jun 21;37(24):1923-8. [Crossref]  [PubMed]
  14. Chen S, Zhang J, Han Y, Kan J, Chen L, Qiu C, et al. Dou- ble Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions: DKCRUSH-V Randomized Tri- al. Journal of the American College of Cardiology. 2017; 70: 2605-2617. [Crossref]  [PubMed]
  15. Hildick-Smith D, Egred M, Banning A, Brunel P, Ferenc M, Hovasse T, et al. The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN). European Heart Journal. 2021; 42: 3829-3839. [Crossref]  [PubMed]
  16. Bukka M, Rednam PJ, Sinha M. Drug-eluting balloon: de- sign, technology and clinical aspects. Biomed Mater. 2018 Feb 23;13(3):032001. [Crossref]  [PubMed]
  17. Cortese B, Silva Orrego P, Agostoni P, Buccheri D, Piraino D, Andolina G, et al. Effect of Drug-Coated Balloons in Na- tive Coronary Artery Disease Left with a Dissection. JACC Cardiovasc Interv. 2015 Dec 28;8(15):2003-2009. [Crossref]  [PubMed]
  18. Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Ep- idemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016 Jul;4(13):256. [Crossref]  [PubMed]  [PMC]
  19. Rathore S, Tehrani S, Prvulovic D, Araya M, Lefèvre T, Banning AP, et al. Drug coated balloons and their role in bifurcation coronary angioplasty: appraisal of the current evidence and future directions. Expert Rev Med Devices. 2020 Oct;17(10):1021-1033. [Crossref]  [PubMed]
  20. Loh JP, Waksman R. Paclitaxel drug-coated balloons: a review of current status and emerging applications in na- tive coronary artery de novo lesions. JACC Cardiovasc Interv. 2012 Oct;5(10):1001-12. [Crossref]  [PubMed]
  21. Dash D, Mody R, Ahmed N, Malan SR, Mody B. Drug-coat- ed balloon in the treatment of coronary bifurcation lesions: A hope or hype? Indian Heart J. 2022 Nov-Dec;74(6):450-457. [Crossref]  [PubMed]  [PMC]
  22. Belkacemi A, Agostoni P, Voskuil M, Stella PR. Coronary bifurcation lesions treated with the drug-eluting balloon: a preliminary insight from the DEBIUT study. EuroInterven- tion. 2011 May;7 Suppl K: K66-9. [Crossref]  [PubMed]
  23. Kleber FX, Rittger H, Bonaventura K, Zeymer U, Wöhrle J, Jeger R, et al. Drug-coated balloons for treatment of coro- nary artery disease: updated recommendations from a con- sensus group. Clin Res Cardiol. 2013 Nov;102(11):785-97. [Crossref]  [PubMed]
  24. Dash D, Ahmed N, Mody R, Thejus J, Reddy S.Drug-coated balloon in percutaneous interventions: a relevant tool or an unwarranted hype? Clinical and Interventional Cardiology, 1(1); DOI:10.31579/cic-2021/001. [Link]
  25. Schulz A., Hauschild T., Kleber F.X. Treatment of coronary de novo bifurcation lesions with DCB only strategy. Clin Res Cardiol. 2014; 103:451-456. [Crossref]  [PubMed]
  26. Kleber FX, Rittger H, Ludwig J, Schulz A, Mathey DG, Box- berger M, Degenhardt R et al. Drug eluting balloons as stand- alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial. Clin Res Cardiol. 2016 Jul;105(7):613-21. [Crossref]  [PubMed]
  27. Bruch L, Zadura M, Waliszewski M, Platonic Z, Eränen J, Scheller B et al. Results from the International Drug Coat- ed Balloon Registry for the Treatment of Bifurcations. Can a Bifurcation Be Treated Without Stents? J Interv Cardi- ol. 2016 Aug;29(4):348-56. [Crossref]  [PubMed]
  28. Her AY, Ann SH, Singh GB, Kim YH, Okamura T, Garg S et al. Serial Morphological Changes of Side-Branch Ostium after Paclitaxel-Coated Balloon Treatment of De Novo Coronary Lesions of Main Vessels. Yonsei Med J. 2016 May;57(3):606-13. [Crossref]  [PubMed]  [PMC]
  29. Her, AY., Kim, B., Kim, S. Kim Y.H., Scheller B. and ShinE.S. Comparison of angiographic change in side-branch osti- um after drug-coated balloon vs. drug-eluting stent vs. med- ication for the treatment of de novo coronary bifurcation le- sions. Eur J Med Res 29, 280 (2024). [Crossref]  [PubMed]  [PMC]
  30. Mathey DG, Wendig I, Boxberger M, Bonaventura K, Kle- ber FX. Treatment of bifurcation lesions with a drug-elut- ing balloon: the PEPCAD V (Paclitaxel Eluting PTCA Bal- loon in Coronary Artery Disease) trial. EuroIntervention. 2011 May;7 Suppl K: K61-5. [Crossref]  [PubMed]
  31. Stella PR, Belkacemi A, Dubois C, Nathoe H, Dens J, Naber C, et al. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial. Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1138-46. [Crossref]  [PubMed]
  32. López Mínguez JR, Nogales Asensio JM, Doncel Vecino LJ, Sandoval J, Romany S, Martínez Romero P, et al; BABI- LON Investigators. A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary le- sions (BABILON trial): 24-month clinical and angiographic results. EuroIntervention. 2014 May;10(1):50-7. [Crossref]  [PubMed]
  33. Berland J, Lefèvre T, Brenot P, Fajadet J, Motreff P, Guerin P, et al; DEBSIDE trial investigators. DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial. EuroIntervention. 2015 Dec;11(8):868-76. [Crossref]  [PubMed]
  34. Worthley S, Hendriks R, Worthley M, Whelan A, Walters DL, Whitbourn R, et al. Paclitaxel-eluting balloon and ever- olimus-eluting stent for provisional stenting of coronary bi- furcations: 12-month results of the multicenter BIOLUX-I study. Cardiovasc Revasc Med. 2015 Oct-Nov;16(7):413-7. [Crossref]  [PubMed]
  35. Jim MH, Lee MK, Fung RC, Chan AK, Chan KT, Yiu KH. Six-month angiographic result of supplementary pacli- taxel-eluting balloon deployment to treat side branch ostium narrowing (SARPEDON). Int J Cardiol. 2015; 187:594-7. [Crossref]  [PubMed]
  36. Sgueglia GA, Todaro D, Bisciglia A, Conte M, Stipo A, Pucci E. Kissing inflation is feasible with all second-gen- eration drug-eluting balloons. Cardiovasc Revasc Med. 2011 Sep-Oct;12(5):280-5. [Crossref]  [PubMed]
  37. Herrador JA, Fernandez JC, Guzman M, Aragon V. Drug-elut- ing vs. conventional balloon for side branch dilation in cor- onary bifurcations treated by provisional T stenting. J Interv Cardiol. 2013 Oct;26(5):454-62. [Crossref]  [PubMed]
  38. Megaly M, Rofael M, Saad M, Shishehbor M, Brilakis ES. Outcomes With Drug-Coated Balloons for Treating the Side Branch of Coronary Bifurcation Lesions. J Invasive Cardi-ol. 2018 Nov;30(11):393-399. [Link]
  39. Jing QM, Zhao X, Han YL, Gao LL, Zheng Y, Li ZQ et al. A drug-eluting Balloon for the trEatment of coronarY bi- furcatiON lesions in the side branch: a prospective multi- center ranDomized (BEYOND) clinical trial in China. Chin Med J (Engl). 2020 Apr 20;133(8):899-908. [Crossref]  [PubMed]  [PMC]
  40. Dan Ke, Xi He, Canqiang Chen, Chaogui Lin, Yukun Luo, Lin Fan, et al. Randomized Pilot Study to Compare DCB- Based versus DST-Based Strategies for the Treatment of True or Complex Coronary Bifurcation Lesions. Rev. Car- diovasc. Med. 2023, 24(4), 99. [Crossref]  [PubMed]  [PMC]
  41. Pan M, Lassen JF, Burzotta F, Ojeda S, Albiero R, Lefèvre T, et al. The 17th expert consensus document of the European Bifurcation Club - techniques to preserve access to the side branch during stepwise provisional stenting. EuroInterven- tion: Journal of Euro PCR in Collaboration with the Working Group on Interventional Cardiology of the European Soci- ety of Cardiology. 2023; 19: 26-36. [Crossref]  [PubMed]  [PMC]
  42. Harada Y, Colleran R, Pinieck S, Giacoppo D, Michel J, Kuf- ner S,et al.A ngiographic and clinical outcomes of patients treated with drug-coated balloon angioplasty for in-stent restenosis after coronary bifurcation stenting with a two- stent technique. EuroIntervention. 2017;12:2132-9. [Crossref]  [PubMed]